| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.3 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |